应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
HARP Harpoon Therapeutics Inc.
停牌 03-08 16:00:00 EST
23.01
+0.00
0.00%
最高
23.01
最低
23.01
成交量
0.00
今开
23.01
昨收
23.01
日振幅
0.00%
总市值
4.92亿
流通市值
2.40亿
总股本
2,140万
成交额
1.52亿
换手率
0.00%
流通股本
1,043万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
多地银行回应“存量房贷利率调降”“存量房贷转按揭”等热点问题
每日经济新闻 · 09-28
多地银行回应“存量房贷利率调降”“存量房贷转按揭”等热点问题
“转按揭”的海外经验，值得当下借鉴吗？
格隆汇 · 09-04
“转按揭”的海外经验，值得当下借鉴吗？
暂无数据
公司概况
公司名称：
Harpoon Therapeutics Inc.
所属市场：
NASDAQ
上市日期：
--
主营业务：
Harpoon Therapeutics, Inc.于2015年3月在特拉华州注册成立。他们是一家临床阶段的免疫治疗公司，开发一种新型T细胞参与者，利用人体免疫系统的力量来治疗患有癌症和其他疾病的患者。使用他们专有的Tri特异性T细胞激活构建体或TriTAC平台，他们正在开发新的T细胞参与者或TriTACs的管道，最初专注于治疗实体瘤和恶性血液病。自2015年开始运营以来，他们已经创建了四个TriTAC候选产品，他们预计到2020年底将有四个TriTAC用于临床开发。
发行价格：
--
{"stockData":{"symbol":"HARP","market":"US","secType":"STK","nameCN":"Harpoon Therapeutics Inc.","latestPrice":23.01,"timestamp":1709931600000,"preClose":23.01,"halted":3,"volume":0,"delay":0,"floatShares":10431362,"shares":21397205,"eps":-8.24673,"marketStatus":"停牌","marketStatusCode":5,"change":0,"latestTime":"03-08 16:00:00 EST","open":23.01,"high":23.01,"low":23.01,"amount":151963167.994,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.24673,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1549602000000,"adjPreClose":23.01,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/HARP/tweets","defaultTab":"tweets","newsList":[{"id":"2470288240","title":"多地银行回应“存量房贷利率调降”“存量房贷转按揭”等热点问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2470288240","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470288240?lang=zh_cn&edition=full","pubTime":"2024-09-28 22:02","pubTimestamp":1727532154,"startTime":"0","endTime":"0","summary":"每经记者：刘嘉魁 每经编辑：马子卿存量房贷利率何时下调？存量房贷跨行转按揭如何实施？针对近日引发市场和购房人热议的新一轮住房金融政策，《每日经济新闻》记者以购房者身份探访多地银行机构，与业内人士深入探讨转按揭业务会对银行和购房者产生哪些影响。“要官方回答不？”某大行个贷中心负责人对记者笑称，近...","market":"hk","thumbnail":"https://inews.gtimg.com/news_ls/OcyFmGybU2Vr9vGbBVaGH25fQSJRbzgTRH7CshcpnC2WgAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/news_ls/OcyFmGybU2Vr9vGbBVaGH25fQSJRbzgTRH7CshcpnC2WgAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240928A07TU500","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240928A07TU500","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["HARP","BK4139"],"gpt_icon":0},{"id":"2464325901","title":"“转按揭”的海外经验，值得当下借鉴吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2464325901","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464325901?lang=zh_cn&edition=full","pubTime":"2024-09-04 17:11","pubTimestamp":1725441108,"startTime":"0","endTime":"0","summary":"海外转按揭政策实施过程中不仅依靠居民和银行，更依赖政府参与和主导。","market":"hk","thumbnail":"https://img3.gelonghui.com/316e3-c3d38059-406a-436f-97f7-a698b8e68c9f.jpg?guru_height=854&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/316e3-c3d38059-406a-436f-97f7-a698b8e68c9f.jpg?guru_height=854&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1002470","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK4139","HARP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.harpoontx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.781},{"period":"ytd","weight":1.0237}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Harpoon Therapeutics, Inc.于2015年3月在特拉华州注册成立。他们是一家临床阶段的免疫治疗公司，开发一种新型T细胞参与者，利用人体免疫系统的力量来治疗患有癌症和其他疾病的患者。使用他们专有的Tri特异性T细胞激活构建体或TriTAC平台，他们正在开发新的T细胞参与者或TriTACs的管道，最初专注于治疗实体瘤和恶性血液病。自2015年开始运营以来，他们已经创建了四个TriTAC候选产品，他们预计到2020年底将有四个TriTAC用于临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.242429},{"month":2,"riseRate":0.6,"avgChangeRate":-0.065166},{"month":3,"riseRate":0.5,"avgChangeRate":-0.060017},{"month":4,"riseRate":0.6,"avgChangeRate":-0.070213},{"month":5,"riseRate":0.6,"avgChangeRate":0.148043},{"month":6,"riseRate":0.4,"avgChangeRate":-0.10251},{"month":7,"riseRate":0.6,"avgChangeRate":-0.072268},{"month":8,"riseRate":0.4,"avgChangeRate":0.073914},{"month":9,"riseRate":0.2,"avgChangeRate":-0.203332},{"month":10,"riseRate":0.2,"avgChangeRate":-0.037937},{"month":11,"riseRate":0.6,"avgChangeRate":0.254169},{"month":12,"riseRate":0.8,"avgChangeRate":0.053145}],"exchange":"NASDAQ","name":"Harpoon Therapeutics Inc.","nameEN":"Harpoon Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Harpoon Therapeutics Inc.(HARP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Harpoon Therapeutics Inc.(HARP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Harpoon Therapeutics Inc.,HARP,Harpoon Therapeutics Inc.股票,Harpoon Therapeutics Inc.股票老虎,Harpoon Therapeutics Inc.股票老虎国际,Harpoon Therapeutics Inc.行情,Harpoon Therapeutics Inc.股票行情,Harpoon Therapeutics Inc.股价,Harpoon Therapeutics Inc.股市,Harpoon Therapeutics Inc.股票价格,Harpoon Therapeutics Inc.股票交易,Harpoon Therapeutics Inc.股票购买,Harpoon Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Harpoon Therapeutics Inc.(HARP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Harpoon Therapeutics Inc.(HARP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}